Candidate methylation sites associated with endocrine therapy resistance in the TCGA ER+/HER2- breast cancer cohort
Maryam Soleimani Dodaran, Simone Borgoni, Emre Sofyalı, Pernette J. Verschure, Stefan Wiemann, Perry D. Moerland, Antoine H. C. van Kampen
The paper identifies DNA methylation markers associated with endocrine therapy resistance in ER+/HER2- breast cancer using TCGA data and cell line experiments.
BMC Cancer · Jul 19, 2020Peer-reviewedBioinformatics